COMUNICACION INTERCELULAR
CTS-101
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (4)
2022
-
Role of 5HT1A Receptors in the Neuroprotective and Behavioral Effects of Cannabidiol in Hypoxic–Ischemic Newborn Piglets
Frontiers in Pharmacology, Vol. 13
2021
-
Randomized placebo-controlled phase II trial of high-dose melatonin mucoadhesive oral gel for the prevention and treatment of oral mucositis in patients with head and neck cancer undergoing radiation therapy concurrent with systemic treatment
Clinical and Translational Oncology, Vol. 23, Núm. 9, pp. 1801-1810
2019
-
Cannabidiol administration prevents hypoxia-ischemia-induced hypomyelination in newborn rats
Frontiers in Pharmacology, Vol. 10, Núm. SEP
2017
-
Neuroprotective effects of cannabidiol in hypoxic ischemic insult. The therapeutic window in newborn mice
CNS and Neurological Disorders - Drug Targets, Vol. 16, Núm. 1, pp. 102-108